Form 10-QSB SEC 2344 (5-99)Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. OMB APPROVAL OMB Number: 3235-0416 Expires: May 31, 2000 Estimated average burden hours per response: 9708.0 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB (Mark One) [ ] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 20, 1999. [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from July 20,1999 to October 20,1999. Commission file number ________ Piccard Medical Corporation _____________________ (Exact name of small business issuer as specified in its charter) 	Delaware _______________ (State or other jurisdiction of incorporation or organization)______41-1716477 (IRS Employer Identification No.) 120 2nd Street P.O. Box 170 Weyerhauser Wi. 54895 _______________________________________ (Address of principal executive offices) ( 715 ) 353- 2810 (Issuer's telephone number) _________N/A___ (Former name, former address and former fiscal year, if changed since last report) APPLICABLE ONLY TO CORPORATE ISSUERS State the number of shares outstanding of each of the issuer's classes of common equity, as of the latest practicable date: __18,205,600 common shares outstanding as of January 1, 2000. Transitional Small Business Disclosure Format (Check one): Yes [ ] No [x ] PART I FINANCIAL INFORMATION Item 1. Financial Statements. PICCARD MEDICAL CORP 19#00 Profit and Loss July 20 through October 20,1999 Jul 20 - Oct 20,'99 Ordinary Income/Expense Income Soles 			 	162,164.95 Sales Discounts 		 	-50,153.65 Uncate9orized Income 		1.10 Total Income 		 	112,032.40 Cost of Goods Sold 	 	30,230.89 Total COGS 		 	30,230.89 Gross Profit 		 	81,801.51 Expense Advertising 	 	 	12,827.32 Automobile Exp. -Co. 	 	2,133.74 Bank Service Charges 	 	135.00 Commission 		 	7,760.91 Contract Labor 		 	800.00 Donations / Contributions 	180.00 Dues and Subscriptions	 	2,827.00 Equipment Rental/Lease 	 	165.60 Freight / Shipping 	 	6,610.25 Insurance 		 	7,672.82 Interest Expense 		3.81 Medical 		 	257.20 Miscellaneous 		 	128.09 PER Penalties 		 	2,029.62 Payroll Expenses 	 	58,485.31 Paroll Taxes 		 	4,922.89 Postage 		 	2,102.00 Professional Fees 	 	9,396.91 Rent 			 	6,745.68 Repairs 		 	121.59 Sales Expense 		 	3,563.61 Supplies 		 	3,119.65 Telephone 		 	1,666.60 Trade Show / Conventions 	3,525.00 Utilities 		 	1,772.08 PICCARD MEDICAL CORP 19/00 Profit and Loss July 20 through October 20.1999 Jul 20 - Oct 20,199 Total Expense 		 	139,212.66 	Net Ordinary Income 		 -57,411.17 	Net Income 			 -57,411.17 PICCARD MEDICAL CORP 19/00 Balance Sheet As of October 20,1999 Oct 20, '99 ASSETS Current Assets Checking/Savings Chippewo Volley Bank 	 	4,309.84 Heritage Credit Union 		3,641.76 Savings-Heritage Credit Union 	72.95 Total Checking/Savings 	 	8,024.55 Accounts Receivable 	 	29,330.62 Total Accounts Receivable 	 	29,330.62 Other Current Assets Inventory 		 		111,816.59 Inventory Asset 		 	-268.94 N/R Stockholder 		 	219,980.46 Petty Cash 		 	100.00 Total Other Current Assets 	331,628.11 Total Current Assets 	 	368,983.28 Fixed Assets Leasehold Improvements 	 	15,972.54 Office/Computer equipment 	 	24,878.19 Shop Equipment/Tools 	 	186,098.56 Vehicles			 	23,178.77 Accumulated Depreciation 	 	-125,628.30 Total Fixed Assets 	 	126,499.76 Other Assets Co-op Capital 		 	18.06 Organization Costs 	 	638.00 Accumulated Amortization 	 	-638.00 Total Other Assets 	 	18.06 TOTAL ASSETS 		 	495,501.10 LIABILITlES & EQUITY Liabilities Current Liabilities PICCARD MEDICAL CORP 19/00 Balance Sheet As of October 20, 1999 Oct 20, 999 Accounts Payable 		124.724.03 Total Accounts Payable 		124,724.03 Other Current Liabilities Accrued Interest 		34,241.72 Payroll Liabilities 	 	46,237.89 Total Other Current Liabilities 	80,479.61 Totat Current Liabilities 	205,203.64 Long Term Liabilities N/P Credit Counselors of Americ 	33,308.05 N/P Chrysler Financial Corp 	26,792.54 N/P Bankers Leasing 	 	68,045.66 Loan-Working Capital 		 7,148.75 N/P Orion Espeseth 	 	30,000.00 N/P Libby Espeseth 	 	59,400.00 N/P NE State Bank-Van 		427.60 N/P Rusk County - Air Cond. 	2,052.30 N/Stockholder-A. Espeseth 	 164,488.94 N/Stockholder JC Capital Corp 	 235,000.00 Total Long Term Liabilities 	626,663.84 Total Liabilities 	 	831.667.48 Equity Additional Paid In Capitol 	866,013.58 Common Stock 		 	5,000.00 Opening Gal Equity 	 	-32,986.67 Retained Earnings 	 	-992.175.84 Net Income 	 		-182,217.45 Total Equity 	 		-336,366.38 TOTAL LIABILITIES & EQUITY 		495,501.10 Furnish the information required by Item 310(b) of Regulation S-B. Item 2. Management's Discussion and Analysis or Plan of Operation. Management believes sales and marketing of the Company's product line will be increasing because of the increase in sales staff. This has however,placed the Company in an operating deficit. The company requires additional capital to increase product line and increase market share of it's existing products. The Company believes it has proprietary products but needs more money to compete in this industry. A plan is being developed to secure these funds and management believes that when accomplished the company could see incremental gains both in market share of existing product and with the development of new innovative products. Without the insurgence of capital management believes the company can continue but will be substantially hindered and may have to lay off personel to lower it's overhead. The Company is losing money and cannot continue sustain these losses for many more quarters. PART II OTHER INFORMATION Item 1. Legal Proceedings. none Item 2. Changes in Securities. ON Dec. 6, 1999 the Company issued 9,102,800 shares of common stock restricted under rule 144 to Mr. David Espeseth, the Company's President and CEO. This increased the total outstanding shares to 18,205,600 from the previous 9,102,800. This was done to keep Mr. Espeseth with the company and ensure his continued commitment to improve the status of the Company. A special meeting was held and a majority of shareholders and all Directors approved the stock issuance to Mr. Espeseth. Item 4. Submission of Matters to a Vote of Security Holders. Item 5. Other Information. On Jan. 19, 2000 the Board of Directors approved the increase in capitalization of the Company from fifty million shares authorized to five hundred million shares authorized. This was accomplished by filing with the State of Delaware an amendment to the articles of incorporation. The intent of this was to provide the Company with sufficient authorized shares to promote sufficient funding to enable the growth of the Company. Item 6. Exhibits and Reports on Form 8-K. (a) Furnish the exhibits required by Item 601 of Regulation S-B. (b) Reports on Form 8-K. State whether any reports on Form 8-K were filed during the quarter for which this report is filed, listing the items reported, any financial statements filed and the dates of such reports. SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Piccard Medical Corporation (Registrant) Date : January 25, 2000. __________________________________ (Signature)*David Espeseth: President, Ceo, Director